日期 2025 年 6 月 26 日, 星期四
时间 10am ET (4pm CET)
解决方案：Early Clinical, Late Clinical
Services: 定量系统药理学咨询
产品： 定量系统药理学
概述
In this joint webinar with Sanofi, we discuss an approach that combines mechanistic modeling with machine learning, to obtain deeper insights and guide therapeutic strategies, for inflammatory bowel disease (IBD).
We begin our webinar with an introduction to QSP, followed by an overview of the virtual patient technology and its application in inflammatory bowel disease (IBD). Our speakers will share a case study to further elucidate applications. And finally, we will have an overall discussion of the impact this approach can have on drug development decision-making. At the end of the webinar, our expert speakers take questions from you.
Key Learning Objectives:
- Familiarize yourself with the current fast-changing landscape and trends in Quantitative Systems Pharmacology (QSP) and its applications in inflammatory bowel disease (IBD)
- Get an overview of the virtual patient technology and applications, followed by a case study
- Learn about the impact of this approach on drug development decision-making
点击报名
Senior Vice President and Head of Quantitative Systems Pharmacology
Piet van der Graaf 现任 Certara 高级副总裁兼 QSP 负责人，同时也是莱顿大学系统药理学教授。Piet 是 2013 - 2016 年莱顿药物研究学术中心的研究主任。1999 - 2013 年，Piet 在辉瑞公司的研发生物学、药代动力学和药物代谢、以及临床药理学等部门担任过多种领导职务。Piet 于2012 - 2018 年担任 CPT: Pharmacometrics & Systems Pharmacology 的创始主编，随后成为 Clinical Pharmacology & Therapeutics 的主编。Piet 曾在伦敦国王学院师从诺贝尔奖获得者 Sir James Black，接受了临床医学的博士培训。他曾获得 2024 年美国临床药理学与治疗学会（ASCPT）颁发的 Gary Neil 药物开发创新奖，同时也是国际定量药理学会（ISoP）2021 年领袖奖的获得者。Piet 是英国药理学会的当选委员，在定量药理学和药物开发领域发表了超过 200 篇同行评议的论文。
Sr Director, QSP
Douglas W. Chung is a highly experienced scientist and consultant specializing in mechanistic modeling to support drug discovery and development. His background is in biomedical engineering and his focus is in quantitative systems pharmacology with over 12 years of experience consulting in biotech and pharmaceuticals. His passion is to grow the field of quantitative pharmacology by expanding diversity in people, fields of expertise, and clinical trial populations.
Head of QSP Germany, Sanofi
As Head of Quantitative Systems Pharmacology Germany, Britta oversees QSP projects and quantitative pharmacology strategy. She advances virtual patient engines and in-silico clinical trials to impact drug research and development, improve portfolio decisions, increase probability of success, and accelerate development of innovative medication for patients, improving people’s lives. With more than 10 years of experience in the pharmaceutical industry, she brings remarkable expertise and proven track record of delivering high value modeling & simulation solutions for diverse modalities across therapeutic areas including immunology & inflammation and metabolism. Britta holds a PhD in Computational Life Science from Luebeck University.
Associate Director of QSP, Sanofi
点击报名
